U.S. market Closed. Opens in 15 hours 44 minutes

FMS | Fresenius Medical Care AG & Co. KGaA Stock Overview

(Stock Exchange: NYSE)
Day's Range N/A - N/A
52 Week Range N/A - N/A
Beta 0.85
Implied Volatility 47.71%
IV Rank 39.27%
Day's Volume N/A
Average Volume N/A
Shares Outstanding N/A
Market Cap N/A
Sector Healthcare
Industry Medical - Care Facilities
IPO Date 1996-09-17
Valuation
Profitability
Growth
Health
P/E Ratio N/A
Forward P/E Ratio 9.69
EPS N/A
1YR Price Target 29.35
Dividend Yield 2.72%
Dividend Per Share N/A
Dividend ExDate 2022-05-13
Dividend PayDate 2022-05-27
Employees 113,079
Country Germany
Website FMS
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
FMS's peers: UHS, ADUS, HCA, THC, SEM, EHC, PNTG, INNV, ACHC, ENSG, SGRY, RMYHY, JNHMF, MFCSF, MCIOF, AIH
*Chart delayed
Analyzing fundamentals for FMS we got that it has average fundamentals where Valuation is considered to be significantly undervalued, Profitability is unacceptably poor, Growth is bad and Health is passable. For more detailed analysis please see FMS Fundamentals page.

Watching at FMS technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on FMS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙